Abstract
Much research effort has been expended over the last two decades in laboratories throughout the world in search of a molecule that possesses all the anabolic properties of the male hormone, testosterone, but does not elicit responses generally characterized as virilizing. These efforts have been justified on the premise that a “pure” anabolic agent would be expected to find many more clinical applications and be more generally accepted by the medical specialists than testosterone and its derivatives, particularly for longterm uses associated with debilitating disease states, slow rate of healing of hard or soft tissue, and, in general, for conditions where conservation of the body’s quantity of protein or replenishment of depleted protein states were sought. The clinical preference for an anabolic over an androgenic agent in the above-listed uses would derive from the view that the androgenic or masculinizing actions of the latter would be unwanted or considered as side-effects particularly for children and women.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albanese, A.A., Lorenze, E.J., Orto, L.A.: Nutritional and metabolic effects of some newer cortex-steroids. N.Y. State J. Med. 61, 3998–4002 (1961).
Allen, E., Doisy, E.A.: Ovarian hormone preliminary report on its localization, extraction, partial purification, and action in test animals. J. Am. med. Ass. 81, 819–821 (1923).
Arnold, A.: Reversal by stanozolol of glucocorticoid induced nitrogen losses in rats. Proceedings 7 th Int’l Congr. Nutrition 5, 846–852 (1966).
Arnold, A., Beyler, A.L., Potts, G.O.: Andro-stanzole, a new orally active anabolic agent. Proc. Soc. exp. Biol. (N.Y.) 102, 184–187 (1959).
Arnold, A., Potts, G.O.: Oral anabolic and androgenic effects of 19-nortestosterone and 17α-methyl-19-nortestosterone. Fed. Proc. Fed. Amer. Soc. exp. Biol. 23, 412 (1964).
Arnold, A., Potts, G.O.: Oral anabolic:androgenic evaluations of four anabolic steroids. Acta endocr. (Kbh.) 52, 489–496 (1966).
Arnold, A., Potts, G.O., Beyler, A.L.: Evaluation of the protein anabolic properties of certain orally active anabolic agents based on nitrogen balance studies in rats. Endocrinology 72, 408–417 (1963a).
Arnold, A., Potts, G.O., Beyler, A.L.: Relative oral anabolic to androgenic activity ratios of androisoxazole, ethylestrenol, methylandrostenol-isoxazole and testosterone. Acta endocr. (Kbh.) 44, 490–498 (1963 b).
Arnold, A., Potts, G.O., Beyler, A.L.: Oral anabolic:androgenic activities of 7α,17α-dimethyl-testosterone, oxymesterone, mestanolone and fluoxymesterone. J. Endocr. 28, 87–92 (1963 c).
Arnold, A., Potts, G.O., Beyler, A.L.: Relative oral anabolic:androgenic activities of testosterone, dihydrotestosterone, 4-hydroxymethyltestosterone, 7α,17α-dimethyltestosterone and 9α-fluoro-11β-hydroxymethyltestosterone. 6 th Intl. Congress of Nutrition, Edinburgh, Aug. 9–15, 161 (1963d).
Barnes, L.E., Stafford, R.O., Guild, M.E., Thole, L.C., Olson, K.J.: A comparison of my-otrophic and androgenic activities of testosterone propionate with 19-nortestosterone and its esters. Endocrinology 55, 77–84 (1954).
Beyler, A.L., Arnold, A., Potts, G.O.: Methods for evaluating anabolic and catabolic agents in laboratory animals. J. Amer. med. Women Ass. 23, 708–721 (1968).
Beyler, A.L., Burnham, D., Potts, G.O.: Reversal by androstanozole of catabolic action of cortisone acetate. 1st International Congress of Endocrinolog, Advanced Abstracts of Short Communications (Fuchs, F. ed.) Periodica, Copenhagen. 829 (1960).
Beyler, A.L., Potts, G.O., Arnold, A.: Influence of molecular unsaturation on hormonal activity pattern of certain heterocyclic steroids. Endocrinology 68, 987–995 (1961).
Bliss, C.I.: Statistical methods in vitamin research. In: György, P. (Ed.): Vitamin Methods, pp. 445–610. New York: Academic Press 1951.
Burnham, D.F., Fanuele, F.: The acute catabolic response of castrated male rats to various glucocorticoids. Fed. Proc. Fed. Amer. Soc. exp. Biol. 21, 191 (1962).
Buzby, G.C., Jr., Walk, C.R., Smith, H.: Totally synthetic steroid hormones. X. Some (±)-13β-ethyl-7α-methylgonane derivatives. J. med. Chem. 9, 782–784 (1966).
Camerino, B., Sala, G.: Anabolic steroids. Prog. Drug Res. 2, 71–134 (1960).
Camerino, B., Sciaky, R.: Structure and effects of anabolic steroids. Pharmac. Therap. B Vol. 233–275 (1975).
Campbell, J.A., Babcock, J.G.: The synthesis of some 7α- and 17α-methyl steroid hormones. J. Amer. chem. Soc. 81, 4069–4074 (1959).
Campbell, J.A., Babcock, J.C.: 7α-Methyltestosterones, A new class of potent anabolic agents. In: Martini, L., Pecile, A. (Eds.): Hormonal Steroids, Vol. 2, pp. 59–67. New York: Academic Press 1965.
Cavallero, C.P.: Relative effectiveness of various steroids in an androgen assay using the exorbitai lacrimal gland of the castrated rat. Acta endocr. (Kbh.) 55, 119–130 (1967).
Čekan, Z., Pelc, B.: Effect of 1-alkyl substitution on the biological action in a series of andro-stanes. Steroids 8, 209–218 (1966).
Church, R.F.R., Kende, A.S., Weiss, M.J.: Diazirines. I. Some observations on the scope of the ammonia-hydroxylamine-0-sulfonic acid diaziridines and diazirines. J. Amer. chem. Soc. 87, 2665–2671 (1965).
Clark, G.M., Mills, D.: Corticosteroid therapy of rheumatoid arthritis supplemented with methandrostenolone. Arthritis Rheumatism 5, 156–162 (1962).
Clauberg, C.: Zur Physiologie und Pathologie der Sexualhormone im Besonderen des Hormones des Corpus luteum. I. Mitteilung. Der biologische Test für das Luteohormon (das spezifische Hormon des Corpus luteum) am infantilen Kaninchen. Zbl. Gynaekol. 54, 2757–2770 (1930).
Clausen, F.W., Freudenberger, C.B.: A comparison of the effects of male and female sex hormones on immature female rats. Endocrinology 25, 585–592 (1939).
Clinton, R.O., Manson, A.J., Stonner, F.W., Beyler, A.L., Potts, G.O., Arnold, A.: Steroidal [3,2-c] pyrazoles. J. Amer. chem. Soc. 81, 1513 (1959).
Cross, A.D., Harrison, I.T., Crabbé, P., Kincl, F.A., Dorfman, R.I.: Steroids. CCLXVII. Potent orally-active anabolic steroids. Steroids 4, 229–235 (1964).
Desaulles, P.A., Krähenbühl, C.: Comparison du spectre d’activité de certains gestagénes de synthése. Acta endocr. (Kbh.) 40, 217–231 (1962).
Desaulles, P.A., Krähenbühl, C., Schüler, W., Bein, H.J.: Etude expérimentale du Dianabol, un novel anabolisant. 17α-methyl-17β-hydroxyandrosta-l,4-diene-3-one. Schweiz. med. Wschr. 89, 1313–1318 (1959).
Dörner, G., Schubert, A.: The myotrophic and androgenic activity of new 4-chlorotestosterone derivatives. Intl. Congress on Hormonal Steroids, Milan, May 14–19, 210 (1962).
Dorfman, R.I., Dorfman, A.S.: The assay of subcutaneously injected androgens in the castrated rat. Acta endocr. (Kbh.) 42, 245–253 (1963).
Dorfman, R.I., Kincl, F.A.: Relative potency of various steroids in an anabolic-androgenic assay using the castrated rat. Endocrinology 72, 259–266 (1963).
Edgren, R.A.: A comparative study of the anabolic and androgenic effects of various steroids. Acta endocr. (Kbh.) 44, Suppl. 87, 3–21 (1963).
Edgren, R.A., Peterson, D.L., Jones, R.C., Nagra, C.L., Smith, H., Hughes, G.A.: Biological effects of synthetic gonanes. Recent Prog. Horm. Res. 22, 305–341 (1966).
Edgren, R.A., Smith, H.: Wy 3475, A new potent orally active anabolic agent. In: Martini, L., Pecile, A. (Eds.): Hormonal Steroids, Vol.2, pp. 161–171. New York: Academic Press 1965.
Eisenberg, E., Gordan, G.S.: The levator ani muscle of the rat as an index of myotrophic activity of steroidal hormones. J. Pharmacol. exp. Ther. 99, 38–44 (1950).
Engel, F.L.: A consideration of the roles of the adrenal cortex and stress in the regulation of protein metabolism. Recent Progr. Hormone Res. 6, 277–313 (1951).
Ercoli, A., Gardi, R., Vitale, R.: Steroid-17β-yl acetals and enol ethers. New classes of orally and parenterally active hormonal derivatives. Chem. Ind. (Lond.) 1962, 1284–1285.
Fox, M., Minot, A.S., Liddle, G.W.: Oxandrolone: A potent anabolic steroid of novel chemical configuration. J. clin. Endocr. 22, 921–924 (1962).
Goodlad, G.A.J., Munro, H.N.: Diet and action of cortisone on protein metabolism. Biochem. J. 73, 343–348 (1959).
Halpern, B., Seakapoulos, P., Bricot, M.: Inhibition of growth of young rats by cortisone and aggravation of this action by testosterone. C.R. Soc. Biol. (Paris) 150, 1311–1316 (1956).
Harding, H.R., Potts, G.O.: The anticatabolic activity of anabolic steroids based on the suppression of cortisone acetate (EAc) induction of liver tryptophan pyrrolase. VFth Pan American Congress of Endocrinology, Mexico D.F. (1965).
Herr, M.E., Hogg, J.A., Levin, R.H.: Synthesis of potent oral anabolic-androgenic steroids. J. Amer. chem. Soc. 78, 500–501 (1956).
Hershberger, J.G., Shipley, E.G., Meyer, R.K.: Myotrophic activity of 19-nortestosterone and other steroids determined by modified levator ani muscle method. Proc. Soc. exp. Biol. (N.Y.) 83, 175–180 (1953).
Irmscher, K., Kraft, H.G., Brückner, K.: Synthesis and anabolic activity of 3-methylene- and 3-methylsteroids of the androstane and 19-norandrostane series. J. med. Chem. 7, 345–347 (1964).
Izzo, J.L., Glasser, S.R.: Comparative effects of glucagon, hydrocortisone and epinephrine on the protein metabolism of the fasting rat. Endocrinology 68, 189–198 (1961).
Junkmann, K., Suchowsky, G.: Untersuchung anabol wirksamer Steroide. Arzneimittel-Forsch. 12, 214–218 (1962).
Kasuya, K., Wolff, M.E.: Uptake of androgen analogs by prostate tissue. J. med. Chem. 16, 832–836 (1973).
Kincl, F.A.: Anabolic steroids. Meth. Hormone Res. 4, 21–76 (1965).
Kincl, F.A., Dorfman, R.L.: Anabolic-androgenic potency of various steroids in a castrated rat assay. Steroids 3, 109–122 (1964).
Klein, M., Parkes, A.S.: The progestin-like action of testosterone and certain related compounds. Proc. roy. Soc. Biol. (Lond.) 121, 574–579 (1937).
Knox, W.E.: L-Tryptophan peroxidase from liver. In: Colowick, S.P., Kaplan, N.O. (Eds.): Methods in Enzymology, Vol.2, pp.242–246. New York: Academic Press 1955.
Knox, W.E., Auerbach, V.H.: The hormonal control of tryptophan peroxidase in the rat. J. biol. Chem. 214, 307–313(1955).
Kochakian, C.D.: Comparison of protein anabolic property of various androgens in the castrated rat. Amer. J. Physiol. 160, 53–61 (1950).
Kochakian, C.D., Moe, J.G., Dolphin, J.: Protein anabolic effect of testosterone propionate in adrenalectomized and normal rats. Amer. J. Physiol. 162, 581–589 (1950).
Kochakian, C.D., Murlin, J.R.: Effect of male hormone on protein and energy metabolism of castrate dogs. J. Nutr. 10, 437–459 (1935).
Kochakian, C.D., Robertson, E.: Adrenal steroids and body composition. J. biol. Chem. 190, 495–503 (1951).
Kochakian, C.D., Webster, J.A.: Effect of testosterone propionate on the appetite, body weight and composition of the normal rat. Endocrinology 63, 737–742 (1958).
Kraft, H.G., Brückner, K.: Anabole und androgene Wirksamkeit von thio-substituierten Steroiden der Androstan-Reihe. Arzneimittel-Forsch. 14, 328–330 (1964).
Krüskemper, H.L.: Über den Einfluß von 1α,7α-Bis(acetylthio)-17α-methyltestosteron und 7α,17α-Dimethyltestosteron auf Parameter der Leberfunktion (Serum Enzym, Bromsulpha-lein-Retention, Gerinnungsfaktoren). Arzneimittel-Forsch. 16, 608–612 (1966).
Krüskemper, H.L.: Anabolic Steroids, pp. 1–236. New York: Academic Press 1968.
Krüskemper, H.L., Breuer, H.: Studies on the anabolic effect and metabolism of 1-methyl-1-androsten-17β-ol-3-one. Intl. Congress on Hormonal Steroids, Milan, May 14–19, 209 (1962).
Landau, R.L., Lugibihl, K.: The effect of dietary protein on the catabolic influence of progesterone. J. clin. Endocr. 21, 1345–1363 (1961).
Landau, R.L., Lugibihl, K.: The catabolic and natriuretic effects of progesterone in man. Recent Progr. Hormone Res. 17, 249–292 (1961 a).
Landau, R.L., Lugibihl, K., Berganstal, D.M., Dimick, D.F.: The metabolic effects of progesterone in man: dose response relationships. J. Lab. clin. Med. 50, 613–620 (1957).
Lauson, H.D., Heller, C.B., Golden, J.B., Severinghaus, E.L.: The immature rat uterus in the assay of estrogenic substances, and a comparison of estradiol, estrone and estriol. Endocrinology 24, 35–44 (1939).
Lennon, H.D., Saunders, F.J.: Anabolic activity of 2-oxa-17α-methyldihydrotestosterone (Ox-androlone) in castrated rats. Steroids 4, 689–697 (1964).
Liddle, G.W., Burke, Jr., H.S.: Anabolic steroids in clinical medicine. Helv. med. Acta 27, 504–513 (1960).
Linet, O.: Interaction between androgenic-anabolic steroids and glucocorticoids. Progr. Drug Res. 14, 140–195 (1970).
Long, C.N.H., Katzin, B., Fry, E.G.: The adrenal cortex and carbohydrate metabolism. Endocrinology 26, 309–344 (1940).
Lyster, S.C., Duncan, C.W.: Anabolic, androgenic and myotrophic activities of derivatives of 7α-methyl-19-nortestosterone. Acta endocr. (Kbh.) 43, 399–411 (1963).
Lyster, S.C., Lund, G.H., Stafford, R.O.: Androgenic and myotrophic properties of orally administered 9-fluoro-11-oxy-methyltestosterones. Endocrinology 58, 781–785 (1956).
Manson, A.J., Stonner, F.W., Neumann, H.C., Christiansen, R.G., Clarke, R.L., Acker-man, J.H., Page, D.F., Dean, J.W., Phillips, D.K., Potts, G.O., Arnold, A., Beyler, A.L., Clinton, R.O.: Steroidal heterocycles. VII. Androstano-[2,3-d]isoxazoles and related compounds. J. med. Chem. 6, 1–9 (1963).
Moran, J.F., Sourkes, T.L.: Induction of tryptophan pyrrolase by α-methyltryptophan and its metabolic significance in vivo. J. biol. Chem. 238, 3006–3008 (1964).
Munro, H.N.: Carbohydrate and fat as factors in protein utilization and metabolism. Physiol. Rev. 31, 449–488 (1951).
Neumann, F., Wiechert, R.: Über anabole und androgene Wirkungen von in C1 und C1C2 substituierten Steroiden. Arzneimittel-Forsch. 15, 1168–1184 (1965).
Nimni, M.E., Geiger, E.: Non-suitability of levator ani method as an index of anabolic effect of steroids. Proc. Soc. exp. Biol. (N.Y.) 94, 606–610 (1957).
Nutting, E.F., Klimstra, P.D., Counsellor, E.: Anabolic-androgenic activity of A-ring modified androstane derivatives. Part I. A comparison of parenteral activity. Part II. A comparison of oral activity. Acta endocr. (Kbh.) 53, 627–635; (1966).
Nutting, E.F., Klimstra, P.D., Counsellor, E.: Anabolic-androgenic activity of A-ring modified androstane derivatives. Part I. A comparison of parenteral activity. Part II. A comparison of oral activity. Acta endocr. (Kbh.) 53, 635–643 (1966).
Olsen, R.E., Jacobs, F.A., Richert, D., Thayer, S.A., Kopp, L.J., Wade, N.J.: The comparative bio-assay of several extracts of the adrenal cortex in tests employing four separate physiologic responses. Endocrinology 35, 430–455 (1944).
Overbeek, G.A., Delver, A., De Visser, J.: Anabolic properties of ethylestrenol. Acta endocr. (Kbh.) 41, 133–139 (1962).
Overbeek, G.A., De Visser, J.A.: A new substance with progestational activity. II. Pharmacological properties. Acta endocr. (Kbh.) 22, 318–329 (1956).
Overbeek, G.A., De Visser, J.A.: A comparison of the myotrophic and androgenic activities of the phenylpropionates and decanoates of testosterone and nandrolone. Acta endocr. (Kbh.) 38, 285–292 (1961).
Overbeek, G.A., De Visser, J.A., Delver, A.: Pharmacological comparisons of anabolic steroids (ethylestrenol, nandrolone esters). Acta endocr. (Kbh.) 39, Suppl.63, 7–17 (1961).
Partridge, J.W., Boling, L., De Wind, L., Margen, S., Kinsell, L.W.: Metabolic and clinical effects of methylandrostenediol in human subjects. J. clin. Endocr. 13, 189–202 (1953).
Perelman, M., Farkas, E., Fornefeld, E.J., Karay, R.J., Rapala, R.T.: A new class of active steroids. The 19-nor-Δ 4,9-3 ketosteroids. J. Amer. chem. Soc. 82, 2402–2403 (1960).
Perrine, J.W.: The anabolic, androgenic and antigonadotrophic properties of five synthetic 19-nortestosterone analogs. Acta endocr. (Kbh.) 37, 376–384 (1961).
Potts, G.O., Arnold, A., Beyler, A.L.: Comparative myotrophic and nitrogen retaining effects of several steroids. Endocrinology 67, 849–854 (1960 a).
Potts, G.O., Arnold, A., Beyler, A.L.: Comparative nitrogen retaining and androgenic activities of certain orally active steroids. Intl. Congress on Hormonal Steroids, Milan, May 14–19, 211 (1962).
Potts, G.O., Beyler, A.L., Burnham, D.F.: Myotrophic and androgenic activities of androstan-azole. A new heterocyclic steroid. Proc. Soc. exp. Biol. (N.Y.) 103, 383–384 (1960b).
Reifenstein, E.C., Jr., Albright, F., Wells, S.L.: The accumulation, interpretation, and presentation of data pertaining to metabolic balances, notably those of calcium, phosphorus, and nitrogen, J. clin. Endocr. 5, 367–395 (1945).
Renzi, A.A., Stein, M., Reilly, P., Dube, V.: The anti-inflammatory activity in rats of Δ 1–17α methyltestosterone and corticosteroids. Fed. Proc. Fed. Am. Soc. exp. Biol. 20, 178 (1961).
Ringold, H.J.: Electronic alteration of the steroid molecule. In: Villee, C.A., Engle, L.L.: (Eds.): Mechanisms of Action of Steroid Hormones, pp.200–232. New York: Pergamon Press 1961.
Ringold, H.J., Batres, E.D., Halpern, O., Necoechea, E.: Steroids. CV. 2-Methyl and 2-hy-droxymethylene-androstane derivatives. J. Amer. chem. Soc. 81, 427–432 (1959).
Rubinstein, H.S., Solomon, M.L.: Growth-stimulating effect of testosterone propionate. Proc. Soc. exp. Biol. (N.Y.) 44, 442–446 (1940).
Ruggieri, P. de, Matscher, R., Gandolfi, C., Chiaramonti, D., Lupo, C., Pietra, E., Cavilli, R.: Un nuovo Steroide avente azione proteoanabolica: Archo Sci. biol. (Bologna) 47, 1–19 (1963).
Sala, G.: Clinical evaluation of the anabolic effect of 4-hydroxy-17α-methyltestosterone. Endocrinology 58, 567–572 (1956).
Sala, G.: Clinical evaluation of the anabolic effect of 4-hydroxy-l7α-methyltestosterone. Helv. med. Acta 27, 519–522 (1960).
Sala, G.: Biological properties of 4-hydroxy-3-keto-Δ 4-steroids. In: Martini, L., Pecile, A. (Eds.): Hormonal Steroids, Vol. 1, pp.67–75. New York: Academic Press 1964.
Sala, G., Baldratti, G.: Myotrophic (anabolic) activity of 4-substituted testosterone analogs. Proc. Soc. exp. Biol. (N.Y.) 95, 22–24 (1957).
Sala, G., Baldratti, G.: A long-acting anabolic steroid: 4-hydroxy-19-nortestosterone 17-cyclo-pentylpropionate. Endocrinology 72, 494–495 (1963).
Sala, G., Baldratti, G., Ronchi, R., Clini, V., Bertuzzolio, C.: Attivita anabolica di una serie di nuovi derivati del testosterone. Sperimentale 106, 490–510 (1956).
Salvioni, E.: Evaluation of the anabolic activity of steroids. Lancet 1962II, 453.
Saunders, F.J., Drill, V.A.: The myotrophic and androgenic effects of 17-ethyl-19-nortestos-terone and related compounds. Endocrinology 58, 567–572 (1956).
Saunders, F.J., Drill, V.A.: Comparative androgenic and anabolic effects of several steroids. Proc. Soc. exp. Biol. (N.Y.) 94, 646–649 (1957).
Saunders, F.J., Drill, V.A.: Some biological activities of 17-ethynyl and 17-alkyl derivatives of 17-hydroxyestrenones. Ann. N.Y. Acad. Sci. 71, 516–531 (1958).
Segaloff, A.: The enhanced local androgenic activity of 19-nor steroids and stabilization of their structure by 7α and 17α-methyl substituents to highly potent androgens by any route of administration. Steroids 1, 299–315 (1963).
Segaloff, A., Gabbard, R.B.: 14-Dehydrogenation as a means of increasing androgenicity when measured by local applications on the chick comb. Steroids 1, 77–89 (1963).
Selye, H.: Effect of dosage on the morphogenetic actions of testosterone. Proc. Soc. exp. Biol. (N.Y.) 46, 142–146 (1941).
Selye, H.: Selective alteration of certain ACTH and glucocorticoid effects by androstene derivatives. Metabolism 4, 403–415 (1955).
Selye, H., Mishra, R.K.: On the ability of methyltestosterone to counteract catabolism in diverse conditions of stress. Arch. int. Pharmacodyn. 117, 444–451 (1958).
Silber, R.H., Porter, C.C.: Nitrogen balance, liver protein repletion and body composition of cortisone treated rats. Endocrinology 52, 518–525 (1953).
Steinetz, B.G., Giannina, T., Butler, M., Popick, F.: Dissociation of anabolic and androgenic properties of steroids by anti-anabolic and anti-androgenic agents in rats. Endocrinology 89, 894–896 (1971).
Strike, D.P., Herbst, D., Smith, H.: Totally synthetic hormones. XVI. The conversion of estr-4en-17β-ol to testosterone and the total synthesis of some 18-methylandrostane and 18-methyl pregnane derivatives. J. med. Chem. 10, 446–451 (1967).
Stucki, J.C., Duncan, G.W., Lyster, S.C.: Anabolic and androgenic activities of 7α,17α-di-methyltestosterone (U-19, 763), a new anabolic agent. Int. Congress on Hormonal Steroids, Milan, May 14–19, 65–66 (1962).
Stucki, J.C., Duncan, G.W., Lyster, D.S.C.: Anabolic and androgenic activities of 7α,17α-di-methyltestosterone (U-19763), A new anabolic steroid. In: Martini, L., Pecile, A. (Eds.): Hormonal Steroids, Vol.2, pp. 119–132. New York: Academic Press 1965.
Stucki, J.C., Forbes, A.D., Northam, J.I., Clark, J.J.: An assay for anabolic steroids employing metabolic balance in the monkey: The anabolic activity of fluoxymesterone and its 11-keto analogue. Endocrinology 66, 585–598 (1960).
Suchowsky, G.K., Junkmann, K.: Anabole Steroide und ihre Nebenwirkungen. Acta endocr. (Kbh.) 39, 68–78 (1962).
Suchowsky, G.K., Junkmann, K.: Recent findings in anabolic steroids. In: Martini, L., Peile, A. (Eds.): Hormonal Steroids, Vol.2, pp. 155–159. New York: Academic Press 1965.
Tainter, M.L., Arnold, A., Beyler, A.L., Burnham, D.F., Potts, G.O., Roth, C.H.: Synthetic anabolic steroids in geriatrics. Medical Times 91, 747–759 (1963 a).
Tainter, M.L., Arnold, A., Beyler, A.L., Coulston, F., Potts, G.O., Roth, C.H.: A summary of the comparative therapeutic actions of stanozolol, an oral anabolic steroid. Clin. Med. 71, 2089–2102 (1964).
Tainter, M.L., Arnold, A., Beyler, A.L., Drobeck, H.P., Potts, G.O., Roth, C.H.: Anabolic therapy in the management of cancer: a summary. J. Amer. Geriat. Soc. 11, 1148–1151 (1963 b).
Tait, J.F., Burstein, S.: In vivo studies of steroid dynamics. In: Pincus, G., Thimann, K.V., Astwood, E.B. (Eds.): The Hormones, Vol.5, pp.441–557. London: Academic Press 1964.
Taussky, H.H., Shorr, E.: A microcolorimetric method for the determination of inorganic phosphorus. J. biol. Chem. 202, 675–685 (1953).
Tomarelli, R.M., Bernhart, F.W.: Oral anabolic activity of (±)-13β,17α-diethyl-17β-hydroxy-gon-4-en-3-one (norbolethone) in a nitrogen retention assay. Steroids 4, 451–456 (1964).
U.S. Pharmacopeia. Design and analysis of biological assays. 16th Revision, pp.873–885. Easton, Pa.: Mack Printing Co. 1960.
Van Wayjen, R.G.A., Buyze, G.: Clinical-pharmacological evaluation of certain anabolic steroids. Acta endocr. (Kbh.) 39, Suppl.63, 18–36 (1961).
Vida, J.A.: Structure-activity theories. In “Androgens and anabolic agents.” Chemistry and pharmacology, 21H. New York: Academic Press 1969.
Winter, C.A., Hollins, H.L., Stebbins, R.B.: The effect of androgenic hormones upon the adrenal atrophy produced by cortisone injections and upon the anti-inflammatory action of cortisone. Endocrinology 52, 123–134 (1953).
Zaffaroni, A.: The effect of alkyl- and electronegative-group substitution on steroidal hormone activity. Acta endocr. (Kbh.) Suppl. 50, 139–145 (1960).
Zderic, J.A., Carpio, H., Ruiz, A., Limen, D.C., Kincl, F., Ringold, H.J.: Steroids. CLXXXIII. New anabolic agents from steroids. J. med. Chem. 1963, 195–198.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Potts, G.O., Arnold, A., Beyler, A.L. (1976). Dissociation of the Androgenic and Other Hormonal Activities from the Protein Anabolic Effects of Steroids. In: Kochakian, C.D. (eds) Anabolic-Androgenic Steroids. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 43. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66353-6_11
Download citation
DOI: https://doi.org/10.1007/978-3-642-66353-6_11
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66355-0
Online ISBN: 978-3-642-66353-6
eBook Packages: Springer Book Archive